Pub. Date : 2013 Apr 5
PMID : 23454556
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | In conclusion, the present study demonstrates that the RTK inhibitor Sunitinib blocks the activation of HSC and angiogenesis suggesting its potential as a drug candidate in pathological conditions like liver fibrosis and hepatocellular carcinoma. | Sunitinib | ret proto-oncogene | Homo sapiens |